Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
- Status
- COMPLETED
- Phase
- PHASE3
Endpoint Validation Study (0524A-015)
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of MK0524A on Flushing Caused by Niacin (0524A-056)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
MK0686 in Postsurgery Dental Pain (0686-002)
- Status
- COMPLETED
- Phase
- PHASE2
MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)
- Status
- TERMINATED
- Phase
- PHASE3
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
- Status
- COMPLETED
- Phase
- PHASE3